Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Tuesday, September 10, 2024
  • 7:00 AM – 7:45 AM ET
    ACCP Annual Meeting Program Committee Meeting (Invitation only)
  • 7:00 AM – 7:45 AM ET
    STEP & ESP Gathering
  • 7:00 AM – 8:00 AM ET
    Continental Breakfast
  • 7:00 AM – 3:30 PM ET
    ACCP Registration Open
  • 8:00 AM – 9:30 AM ET
    Symposium 11: Hot Topics: Current Bioethical Challenges in Clinical Research & Drug Development: A Joint ACCP & NYU Grossman School of Medicine Symposium
    Co-Chair & Faculty: Alison Bateman-House, PhD (she/her/hers) – New York Univ Grossman School of Medicine
    Co-Chair & Faculty: Kenneth T. Moore, PhD (he/him/his) – Janssen Scientific Affairs LLC, a Johnson & Johnson Co
    Faculty: Kellie Owens, PhD (she/her/hers) – New York Univ Grossman School of Medicine
    Clinical Trial Designs
     CE: 1.5
  • 8:00 AM – 9:30 AM ET
    Symposium 12: Towards Optimal Dosing in Malnutrition: Innovations for Improved Health Outcomes
    Co-Chair & Faculty: Vikram Gota, MD – Advance Ctr for Treatment Research & Education in Cancer, Tata Memorial Ctr
    Co-Chair & Faculty: Meenakshi Srinivasan, PharmD (she/her/hers) – GSK plc
    Faculty: Rada Savic, PhD (she/her/hers) – Univ of California San Francisco
    Faculty: Erik Sjögren, PhD – Pharmetheus ab
    Specific Populations
     CE: 1.5
  • 9:30 AM – 10:00 AM ET
    Coffee & Networking Break
  • 10:00 AM – 11:30 AM ET
    Symposium 13: Advancements in Understanding Drug-induced Hypersensitivity Reactions
    Chair & Faculty: Santiago Alvarez-Arago, MD (he/him/his) – Johns Hopkins Univ School of Medicine
    Faculty: Melanie C. Dispenza, MD – Johns Hopkins Univ School of Medicine
    Faculty: Elizabeth Phillips, MD – Vanderbilt Univ Medical Ctr
    Translational Clinical Pharmacology
     CE: 1.5
  • 10:00 AM – 11:30 AM ET
    Symposium 14: At the Precipice of Induction-based Drug-Drug Interactions: An Opportunity to Define the Path Forward
    Co-Chair & Faculty: Diane Ramsden, BSc (she/her/hers) – Korrobio Inc
    Co-Chair & Faculty: Xinning Yang, PhD (he/him/his) – US Food & Drug Administration
    Faculty: Tamara D. Cabalu, PhD – Merck & Co Inc
    Translational Clinical Pharmacology
     CE: 1.5
  • 11:30 AM – 1:30 PM ET
    Lunch Buffet
  • 11:45 AM – 1:15 PM ET
    Lunch & Annual Business Meeting (Open to All)
  • 1:30 PM – 3:00 PM ET
    Symposium 15: Project Optimus: A Paradigm Shift in Quantitative Clinical Pharmacology or Business as Usual? Part 1
    Co-Chair & Faculty: Nan Zheng, PhD – US Food & Drug Administration
    Co-Chair & Faculty: Honghui Zhou, PhD – Jazz Pharmaceuticals Inc
    Faculty: Brian Booth, PhD – US Food & Drug Administration
    Faculty: Chunze Li, PhD – Genentech Inc
    Faculty: Bernd Meibohm, PhD, FCP, FAAPS – The Univ of Tennessee Health Science Ctr
    Faculty: Weirong Wang, PhD – Janssen Research & Development
    Clinical Trial Designs
     CE: 1.5
  • 1:30 PM – 3:00 PM ET
    Symposium 16: New Perspectives on Drug Evaluation in Older Adults
    Co-Chair & Faculty: Federica Ferrari, MD, MSc, PhD – Univ of Pavia - IRCCS Mondino Fdtn
    Co-Chair & Faculty: Manjunath Amit Pai, PharmD – Univ of Michigan
    Faculty: Luigi Ferrucci, MD, PhD – National Inst of Health
    Faculty: Rajanikanth Madabushi, PhD – US Food & Drug Administration
    Specific Populations
     CE: 1.5
  • 3:00 PM – 3:30 PM ET
    Coffee & Networking Break
  • 3:30 PM – 5:00 PM ET
    Symposium 15: Project Optimus: A Paradigm Shift in Quantitative Clinical Pharmacology or Business as Usual? Part 2
    Co-Chair & Faculty: Nan Zheng, PhD – US Food & Drug Administration
    Co-Chair & Faculty: Honghui Zhou, PhD – Jazz Pharmaceuticals Inc
    Faculty: Brian Booth, PhD – US Food & Drug Administration
    Faculty: Chunze Li, PhD – Genentech Inc
    Faculty: Bernd Meibohm, PhD, FCP, FAAPS – The Univ of Tennessee Health Science Ctr
    Faculty: Weirong Wang, PhD – Janssen Research & Development
    Clinical Trial Designs
     CE: 1.5
  • 3:30 PM – 5:00 PM ET
    Symposium 17: Hot Topics: Advancements in Antisense Oligonucleotide Development: Challenges, Strategies & Novel Approaches
    Co-Chair & Faculty: Reena Kartha, MS, PhD (she/her/hers) – Ctr for Orphan Drug Research, Coll of Pharmacy, Univ of Minnesota
    Co-Chair & Faculty: Natalie Schmitz, PharmD, PhD – Biogen Inc
    Faculty: Michael Monine, PhD – Biogen Inc
    Faculty: Emily Noonan Place, PhD, MPH (she/her/hers) – Aclairo Pharmaceutical Development Group Inc
    Translational Clinical Pharmacology
     CE: 1.5